Known targets — ChEMBL curated mechanism
GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ
The experimentally established mechanism targets of Chlordiazepoxide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP known ✓ | O00591 | 1/20 | 0.31 |
| ▸ | GABRD known ✓ | O14764 | 1/20 | 0.31 |
| ▸ | GABRA1 known ✓ | P14867 | 1/20 | 0.31 |
| ▸ | GABRB1 known ✓ | P18505 | 1/20 | 0.31 |
| ▸ | GABRG2 known ✓ | P18507 | 1/20 | 0.31 |
| ▸ | GABRB3 known ✓ | P28472 | 1/20 | 0.31 |
| ▸ | GABRA5 known ✓ | P31644 | 1/20 | 0.31 |
| ▸ | GABRA3 known ✓ | P34903 | 1/20 | 0.31 |
| ▸ | GABRA2 known ✓ | P47869 | 1/20 | 0.31 |
| ▸ | GABRB2 known ✓ | P47870 | 1/20 | 0.31 |
| ▸ | GABRA4 known ✓ | P48169 | 1/20 | 0.31 |
| ▸ | GABRE known ✓ | P78334 | 1/20 | 0.31 |
| ▸ | GABRA6 known ✓ | Q16445 | 1/20 | 0.31 |
| ▸ | GABRG1 known ✓ | Q8N1C3 | 1/20 | 0.31 |
| ▸ | GABRG3 known ✓ | Q99928 | 1/20 | 0.31 |
| ▸ | GABRQ known ✓ | Q9UN88 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chlordiazepoxide SCHEMBL19181183 | 1.00 | CYP1A2 (0.59) | CYP1A2KDM4ETP53RXFP1RPS6KA3 | |
| Chlordiazepoxide SCHEMBL5974493 | 1.00 | CYP1A2 (0.59) | CYP1A2KDM4ETP53RXFP1RPS6KA3 | |
| Chlordiazepoxide SCHEMBL9069069 | 1.00 | CYP1A2 (0.59) | CYP1A2KDM4ETP53RXFP1RPS6KA3 | |
| Chlordiazepoxide SCHEMBL15873851 | 0.99 | CYP1A2 (0.58) | CYP1A2KDM4ETP53RXFP1RPS6KA3 | |
| Chlordiazepoxide SCHEMBL28570469 | 0.99 | CYP1A2 (0.58) | CYP1A2KDM4ETP53RXFP1RPS6KA3 | |
| Chlordiazepoxide SCHEMBL5163777 | 0.99 | CYP1A2 (0.58) | CYP1A2KDM4ETP53RXFP1RPS6KA3 | |
| Chlordiazepoxide SCHEMBL20839240 | 0.99 | CYP1A2 (0.58) | CYP1A2KDM4ETP53RXFP1RPS6KA3 | |
| Chlordiazepoxide SCHEMBL15774279 | 0.99 | CYP1A2 (0.58) | CYP1A2KDM4ETP53RXFP1RPS6KA3 | |
| Chlordiazepoxide SCHEMBL10887473 | 0.99 | CYP1A2 (0.60) | CYP1A2KDM4ETP53RXFP1RPS6KA3 | |
| Chlordiazepoxide SCHEMBL29358041 | 0.99 | CYP1A2 (0.60) | CYP1A2KDM4ETP53RXFP1RPS6KA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 14273 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12525764-B2 | Devices for generation of electromagnetic radiation of predetermined profile | Terahertz Group Ltd. (IL) | 2026-01-13 | — | — | US | claimed |
| US-20250345507-A2 | MEDICAL TREATMENT SYSTEM AND METHODS USING A PLURALITY OF FLUID LINES | DEKA PRODUCTS LIMITED PARTNERSHIP (US) | 2025-11-13 | — | — | US | claimed |
| CN-120046576-A | Physical layer PIPE interface enhancement verification method based on PCIE protocol | 成都电科星拓科技有限公司 | 2025-05-27 | — | — | CN | claimed |
| US-20250150972-A1 | USER EQUIPMENT AND SCHEDULING NODE | PANASONIC IP CORP AMERICA (US) | 2025-05-08 | — | — | US | claimed |
| EP-4540944-A1 | METHOD FOR COMPUTING AN ESTIMATED DATA AVAILABILITY FOR UPLINK CONTROL DATA | John Mezzalingua Associates, LLC (US) | 2025-04-23 | — | — | EP | claimed |
| WO-2025024501-A1 | NEUROMODULATORY PEPTIDES | LACTOCORE, INC. (US) | 2025-01-30 | — | — | WO | claimed |
| EP-4483950-A2 | DEVICE FOR UNATTENDED TREATMENT OF A PATIENT | BTL Healthcare Technologies a.s. (CZ) | 2025-01-01 | — | — | EP | claimed |
| WO-2024249914-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING DYSTONIA | DUKE UNIVERSITY (US) | 2024-12-05 | — | — | WO | claimed |
| EP-4469329-A1 | SYSTEMS AND METHODS FOR CONTROLLING A TRAILER SEPARATELY FROM A VEHICLE | TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) | 2024-12-04 | — | — | EP | claimed |
| CN-113573723-B | Synthetic neuromodulatory peptides | 拉托科公司 | 2024-12-03 | — | — | CN | claimed |
| US-3987965-A | WATER VALVE | PUMA ANTHONY R | 1976-10-26 | — | — | US | claimed |
| US-3987398-A | Remote disconnect-reconnect tap for cable television systems | PREMIER CABLEVISION LIMITED (CA) | 1976-10-19 | — | — | US | claimed |
| US-3985426-A | Light beam deflection resolution amplifier means | MCNANEY JOSEPH T | 1976-10-12 | — | — | US | claimed |
| US-3983465-A | Electric braking control apparatus for DC motor | HITACHI, LTD. (JA) | 1976-09-28 | — | — | US | claimed |
| US-3979643-A | Logic driver circuit with output protection | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1976-09-07 | — | — | US | claimed |
| US-3979183-A | Heat exchange and flow control system for series flow reactors | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-09-07 | — | — | US | claimed |
| US-3974400-A | Limiter circuit | SONY CORPORATION (JA) | 1976-08-10 | — | — | US | claimed |
| US-3963983-A | PULSE AMPLITUDE DISCRIMINATING CIRCUIT | COULTER ELECTRONICS, INC. (US) | 1976-06-15 | — | — | US | claimed |
| US-3956615-A | Transaction execution system with secure data storage and communications | IBM CORPORATION (US) | 1976-05-11 | — | — | US | claimed |
| US-3934126-A | Control device for a dragline excavator | ZALESOV OLEG ALEXANDROVICH | 1976-01-20 | — | — | US | claimed |